SV Health Investors
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies
Mestag Therapeutics develops antibody treatments based on fibroblast immunology for cancer and inflammatory diseases. It is building therapies designed to direct and drive immune responses using fibroblast-immune biology.
Artios Pharma lands £90m Series D led by SV Health Investors and RA Capital Management to advance DNA damage response therapeutics
Artios Pharma develops cancer treatments that target DNA damage response pathways, focusing on patient groups with limited existing treatment options.
Alchemab Therapeutics raises £24m Series A extension led by Ono Venture Investment to advance AI-enabled antibody platform
Alchemab identifies naturally occurring protective antibodies using AI and patient data, developing new therapies based on disease resilience rather than traditional target discovery.
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.
TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments
TRIMTECH Therapeutics develops targeted protein degradation medicines that selectively remove harmful protein aggregates, focusing on neurodegenerative and inflammatory diseases with limited existing treatment options.
More venture news
- 11 Jun 2026
Friday4:30Friday4:30 lands £335k in funding from Haatch for incident response software for food and drink brands
EquitySupply Chain - 12 Jun 2026
Spotless WaterSpotless Water secures £6.4m in funding led by YFM Equity Partners for its UK-wide network of pure water refill stations
EquityIndustrial - 11 Jun 2026
Space ForgeSpace Forge lands £10m from ESA to develop reusable heat shield for return of space-manufactured materials
EquityDeep Tech
